07/20/2018
Dr Hyman Scott from the UCSF-Glastone Center for AIDS Research discusses pre-exposure prophylaxis (PrEP) therapy, its indications, and clinical data surrounding its use.
Hyman Scott, MD, MPH, is the Clinical Research Medical Director at Bridge HIV in the San Francisco Department of Public Health (SFDPH) and an Assistant Clinical Professor of Medicine at the University of California, San Francisco (UCSF).
